App-Quantinova.ai

Neuroinflammation, functional connectivity and structural network integrity in Alzheimer’s spectrum

Fangda Leng - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

18F-flutemetamol

Preclinical modelling in the mouse of altered neuroinflammation in Alzheimer’s disease – Down syndrome

Paige Mumford - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alzheimer's disease

Interferon

Fixel-based analysis of the effect of amyloid beta on white matter tracts in neurologically normal 70-year olds.

Aaron Z Wagen - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

18F-florbetapir

Associations of fully automated Elecsys CSF and novel plasma biomarkers with Alzheimer's disease neuropathology

Michel J. Grothe - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

Florbetapir

CSF apolipoprotein B levels predict future visuospatial cognitive decline and synaptic pathology in cognitively unimpaired healthy elderly with a parental history of Alzheimer’s disease

Judes Poirier - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

Flutafuranol F18

Developing Biomarkers of TDP-43-related Splicing Dysfunction in Frontotemporal Dementia

Sahba Seddighi - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

TDP-43

Presence of co-pathology in sporadic early-onset Alzheimer disease vs. Dominantly Inherited Alzheimer Disease.

Jorge J Llibre-Guerra - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Qualitative study of how care is planned and delivered to people living with dementia and a long-term condition

Jessica Rees - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

A Data-Driven Examination of Clustering of Apathy and Depression Symptoms in People with Dementia

Miguel Vasconcelos Da Silva - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Atrophy in dopaminergic pathways is associated with emergence of delusions in patients with Alzheimer’s disease.

Riccardo Manca - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Brain Health Actions: evidence from the electronic Person-Specific Outcome Measure (ePSOM) development programme

Craig W. Ritchie - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Reliability and Participant Acceptance of Remotely Administered RBANS in a MCI and Alzheimer’s Disease Cohort

Matthew B Hunter - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Alzheimer's disease

N/A

Self and informant-rated mild behavioral impairment and genetic risk for AD – the respondent matters

Byron Creese - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Survey in people with dementia and their care partners on post-diagnostic care in memory clinics: data from the COGNISANCE study.

Maud Hevink - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

The Cambridge Behavioural Inventory (Revised) detects early behavioural and functional impairment in genetic frontotemporal dementia within the GENFI cohort.

Annabel Nelson - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

The UK Memory Services National Accreditation Programme (MSNAP)

Martin Orrell - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Hypertension, brain training and cognition in the healthy adults aged over 50 years: an online longitudinal study

Latha Velayudhan - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

A remote digital tool for diagnosis and monitoring of Alzheimer’s Disease

Chris Kalafatis - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

A stepwise approach towards diagnostic workup in dementia, using online cognitive tools.

Aniek M Van Gils - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Economic burden of dementia studies in lowand middleincome countries (LMICs): A systematic review.

Siti Maisarah Mattap - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Filters

45280 Abstracts